We have detected that you are using some form of ad-blocking or filtering.
Please consider white-listing Labnodes since 1) ad-blockers like uBlock break Labnodes functionality and 2) Labnodes does not serve ads.
Rebecca Ihrie Laboratory
|Start Date / Time||November 16, 2016 at 9:00 AM|
|End Date / Time||November 16, 2016 at 10:00 AM|
|Location||9455 MRB IV|
|Presenter Name||Justine Sinnaeve, Grad Student (Ihrie Laboratory)|
|Presentation Title||"Dissecting brain tumor response to therapy at single-cell resolution"|
|Status||This meeting has already occurred|
Glioblastoma is a primary brain cancer with very poor prognosis despite aggressive standard of care therapy. Our current understanding of the effect of standard of care on tumor cells and how tumors ultimately recur is incomplete. Using mass cytometry we will investigate cell phenotypes that escape treatment and may contribute to tumor repopulation.
© 2010-2019. All Rights Reserved to Vanderbilt University. Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Released March 26, 2019